NPORT-EX 2 NPORT_MGGB_94048594_0323.htm

 

Morgan Stanley India Investment Fund, Inc.

Portfolio of Investments

First Quarter Report

March 31, 2023 (unaudited)

 

   Shares   Value
(000)
 
Common Stocks (100.0%)          
Air Freight & Logistics (1.3%)          
Delhivery Ltd. (a)   800,136   $3,231 
           
Automobile Components (1.5%)          
Samvardhana Motherson International Ltd.   4,569,836    3,744 
           
Automobiles (6.4%)          
Bajaj Auto Ltd.   131,851    6,237 
Mahindra & Mahindra Ltd.   665,790    9,409 
         15,646 
Banks (25.2%)          
Axis Bank Ltd.   1,473,392    15,436 
Federal Bank Ltd.   3,628,098    5,858 
HDFC Bank Ltd. ADR   106,616    7,108 
ICICI Bank Ltd.   2,323,602    24,831 
State Bank of India   1,353,893    8,655 
         61,888 
Chemicals (5.7%)          
Aarti Industries Ltd.   391,598    2,476 
Pidilite Industries Ltd.   108,418    3,110 
SRF Ltd.   174,878    5,146 
Supreme Industries Ltd.   108,228    3,315 
         14,047 
Construction & Engineering (4.6%)          
KEC International Ltd.   647,660    3,602 
Larsen & Toubro Ltd.   290,760    7,675 
         11,277 
Consumer Finance (7.0%)          
Cholamandalam Investment & Finance Co. Ltd.   760,090    7,062 
Mahindra & Mahindra Financial Services Ltd.   2,095,284    5,926 
SBI Cards & Payment Services Ltd.   467,315    4,218 
         17,206 
Consumer Staples Distribution & Retail (1.7%)          
Keystone Realtors Ltd. Anchor (a)   218,592    1,233 
Medplus Health Services Ltd. (a)   360,830    2,853 
         4,086 
Financial Services (2.7%)          
Aavas Financiers Ltd. (a)   149,552    2,938 
Home First Finance Co. India Ltd. (a)   401,948    3,642 
         6,580 
Food Products (0.9%)          
Bikaji Foods International Ltd. Anchor (a)   246,675    1,091 
Bikaji Foods International Ltd. (a)   248,746    1,100 
         2,191 

 

 

 

 

Morgan Stanley India Investment Fund, Inc.

Portfolio of Investments

First Quarter Report

March 31, 2023 (unaudited)(cont’d)

 

Health Care Providers & Services (2.2%)          
Apollo Hospitals Enterprise Ltd.   99,727    5,245 
           
Hotels, Restaurants & Leisure (3.5%)          
MakeMyTrip Ltd. (a)   173,955    4,257 
Zomato Ltd. (a)   6,945,319    4,343 
         8,600 
Household Durables (2.1%)          
Crompton Greaves Consumer Electricals Ltd.   1,421,914    5,079 
           
Information Technology Services (11.6%)          
Infosys Ltd.   1,249,435    21,844 
Tech Mahindra Ltd.   494,628    6,668 
         28,512 
Insurance (6.6%)          
ICICI Prudential Life Insurance Co. Ltd.   892,914    4,745 
SBI Life Insurance Co. Ltd.   594,689    7,978 
Star Health & Allied Insurance Co. Ltd. (a)   537,676    3,401 
         16,124 
Office REITs (0.5%)          
Embassy Office Parks REIT   334,387    1,270 
           
Oil, Gas & Consumable Fuels (6.8%)          
Reliance Industries Ltd.   589,882    16,773 
           
Personal Care Products (3.8%)          
Godrej Consumer Products Ltd. (a)   786,710    9,285 
           
Pharmaceuticals (4.2%)          
Alkem Laboratories Ltd.   166,032    6,875 
Gland Pharma Ltd. (a)   221,737    3,431 
         10,306 
Real Estate Management & Development (1.7%)          
Keystone Realtors Ltd. (a)   337,547    1,904 
Sobha Ltd.   447,421    2,352 
         4,256 
TOTAL COMMON STOCKS (Cost $207,548)        245,346 
           
SHORT-TERM INVESTMENT (0.8%)          
Investment Company (0.8%)          
Morgan Stanley Institutional Liquidity Funds - Government Portfolio - Institutional Class (b) (Cost $1,958)   1,958,094    1,958 
TOTAL INVESTMENTS (100.8%) (Cost $209,506) (c)(d)(e)        247,304 
LIABILITIES IN EXCESS OF OTHER ASSETS (-0.8%)        (1,848)
NET ASSETS (100.0%)       $245,456 

 

(a)

Non-income producing security.
(b) The Fund invests in the Institutional Class of the Morgan Stanley Institutional Liquidity Funds - Government Portfolio - (the "Liquidity Funds"), an open-end management investment company managed by the Adviser. Advisory fees paid by the Fund are reduced by an amount equal to its pro-rata share of the advisory and administration fees paid by the Fund due to its investment in the Liquidity Funds. For the three months ended March 31, 2023, advisory fees paid were reduced by approximately $3,000 relating to the Fund's investment in the Liquidity Funds.
(c) The approximate fair value and percentage of net assets, $230,977,000 and 94.1%, respectively, represent the securities that have been fair valued under the fair valuation policy for international investments as described in the Notes to the Portfolio of Investments.
(d) The Fund is permitted to purchase and sell securities ("cross-trade") from and to other Morgan Stanley Funds as well as other funds and client accounts for which the Adviser or an affiliate of the Adviser serves as investment adviser, pursuant to procedures approved by the Directors in compliance with Rule 17a-7 under the Act (the "Rule"). Each cross-trade is executed at the current market price in compliance with provisions of the Rule. For the three months ended March 31, 2023, the Fund did not engage in any cross-trade transactions.
(e) At March 31, 2023, the aggregate cost for federal income tax purposes approximates the aggregate cost for book purposes. The aggregate gross unrealized appreciation is approximately $49,707,000 and the aggregate gross unrealized depreciation is approximately $11,909,000, resulting in net unrealized appreciation of approximately $37,798,000.
ADR American Depositary Receipt.
REIT Real Estate Investment Trust.

 

 

 

 

Portfolio Composition

 

Classification  Percentage of
Total Investments
 
Other*   31.2%
Banks   25.0 
Information Technology Services   11.5 
Consumer Finance   7.0 
Oil, Gas & Consumable Fuels   6.8 
Insurance   6.5 
Automobiles   6.3 
Chemicals   5.7 
Total Investments   100.0%

 

* Industries and/or investment types representing less than 5% of total investments.

 

 

 

 

Morgan Stanley India Investment Fund, Inc.

 

Notes to the Portfolio of Investments March 31, 2023 (unaudited)

 

Security Valuation: (1) An equity portfolio security listed or traded on an exchange is valued at its latest reported sales price (or at the exchange official closing price if such exchange reports an official closing price), and if there were no sales on a given day and if there is no official exchange closing price for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available on the relevant exchanges. If only bid prices are available then the latest bid price may be used. Listed equity securities not traded on the valuation date with no reported bid and asked prices available on the exchange are valued at the mean between the current bid and asked prices obtained from one or more reputable brokers/dealers. In cases where a security is traded on more than one exchange, the security is valued on the exchange designated as the primary market; (2) all other equity portfolio securities for which over-the-counter (“OTC”) market quotations are readily available are valued at the latest reported sales price (or at the market official closing price if such market reports an official closing price), and if there was no trading in the security on a given day and if there is no official closing price from relevant markets for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available on the relevant markets. An unlisted equity security that does not trade on the valuation date and for which bid and asked prices from the relevant markets are unavailable is valued at the mean between the current bid and asked prices obtained from one or more reputable brokers/dealers; (3) fixed income securities may be valued by an outside pricing service/vendor approved by the Fund's Board of Directors (the "Directors"). The pricing service/vendor may employ a pricing model that takes into account, among other things, bids, yield spreads and/or other market data and specific security characteristics. If Morgan Stanley Investment Management Inc. (the "Adviser") or Morgan Stanley Investment Management Company (“MSIM Company”) (the “Sub-Adviser”), each a wholly-owned subsidiary of Morgan Stanley, determines that the price provided by the outside pricing service/vendor does not reflect the security's fair value or is unable to provide a price, prices from brokers/dealers may also be utilized. In these circumstances, the value of the security will be the mean of bid and asked prices obtained from brokers/dealers; (4) when market quotations are not readily available, as defined by Rule 2a-5 under the Act, including circumstances under which the Adviser or the Sub-Adviser determines that the closing price, last sale price or the mean between the last reported bid and asked prices are not reflective of a security’s market value, portfolio securities are valued at their fair value as determined in good faith under procedures approved by and under the general supervision of the Directors. Occasionally, developments affecting the closing prices of securities and other assets may occur between the times at which valuations of such securities are determined (that is, close of the foreign market on which the securities trade) and the close of business of the New York Stock Exchange (“NYSE”). If developments occur during such periods that are expected to materially affect the value of such securities, such valuations may be adjusted to reflect the estimated fair value of such securities as of the close of the NYSE, as determined in good faith by the Directors or by the Adviser using a pricing service and/or procedures approved by the Directors; (5) foreign exchange transactions ("spot contracts") and foreign exchange forward contracts ("forward contracts") are valued daily using an independent pricing vendor at the spot and forward rates, respectively, as of the close of the NYSE; and (6) investments in mutual funds, including the Morgan Stanley Institutional Liquidity Funds, are valued at the net asset value as of the close of each business day.

 

In connection with Rule 2a-5 of the Act, the Directors have designated the Fund's Adviser as its valuation designee. The valuation designee has responsibility for determining fair value and to make the actual calculations pursuant to the fair valuation methodologies previously approved by the Directors. Under procedures approved by the Directors, the Fund's Adviser, as valuation designee, has formed a Valuation Committee whose members are approved by the Directors. The Valuation Committee provides administration and oversight of the Fund’s valuation policies and procedures, which are reviewed at least annually by the Directors. These procedures allow the Fund to utilize independent pricing services, quotations from securities and financial instrument dealers and other market sources to determine fair value.

 

 

 

 

Fair Value Measurement: Financial Accounting Standards Board (“FASB”) Accounting Standards CodificationTM ("ASC") 820, "Fair Value Measurement" (“ASC 820”), defines fair value as the price that would be received to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 establishes a three-tier hierarchy to distinguish between (1) inputs that reflect the assumptions market participants would use in valuing an asset or liability developed based on market data obtained from sources independent of the reporting entity (observable inputs) and (2) inputs that reflect the reporting entity's own assumptions about the assumptions market participants would use in valuing an asset or liability developed based on the best information available in the circumstances (unobservable inputs) and to establish classification of fair value measurements for disclosure purposes. Various inputs are used in determining the value of the Fund's investments. The inputs are summarized in the three broad levels listed below:

 

Level 1 – unadjusted quoted prices in active markets for identical investments

 

Level 2 – other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)

 

Level 3 – significant unobservable inputs including the Fund’s own assumptions in determining the fair value of investments. Factors considered in making this determination may include, but are not limited to, information obtained by contacting the issuer, analysts, or the appropriate stock exchange (for exchange-traded securities), analysis of the issuer's financial statements or other available documents and, if necessary, available information concerning other securities in similar circumstances.

 

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities and the determination of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each security.

 

The following is a summary of the inputs used to value the Fund's investments as of March 31, 2023:

 

Investment Type  Level 1
Unadjusted
quoted
prices
(000)
   Level 2
Other
significant
observable
inputs
(000)
   Level 3
Significant
unobservable
inputs
(000)
   Total
(000)
 
Assets:                    
Common Stocks                    
Air Freight & Logistics  $    3,231   $   $3,231 
Automobile Components       3,744        3,744 
Automobiles       15,646        15,646 
Banks   7,108    54,780        61,888 
Chemicals       14,047        14,047 
Construction & Engineering       11,277        11,277 
Consumer Finance       17,206        17,206 
Consumer Staples Distribution & Retail       4,086        4,086 
Financial Services       6,580        6,580 
Food Products   1,100    1,091        2,191 
Health Care Providers & Services       5,245        5,245 
Hotels, Restaurants & Leisure   4,257    4,343        8,600 
Household Durables       5,079        5,079 
Information Technology Services       28,512        28,512 
Insurance       16,124        16,124 
Office REITs       1,270        1,270 
Oil, Gas & Consumable Fuels       16,773        16,773 
Personal Care Products       9,285        9,285 
Pharmaceuticals       10,306        10,306 
Real Estate Management & Development   1,904    2,352        4,256 
Total Common Stocks   14,369    230,977        245,346 
Short-Term Investment                    
Investment Company   1,958            1,958 
Total Assets  $16,327   $230,977   $   $247,304 

 

Transfers between investment levels may occur as the markets fluctuate and/or the availability of data used in an investment's valuation changes.